New Stock News | Zhiyuan Pharmaceutical Submits Application to Hong Kong Stock Exchange
According to the disclosure by the Hong Kong Stock Exchange on July 9, Jiangsu Zhiyuan Pharmaceutical Co., Ltd. (referred to as Zhiyuan Pharmaceutical) submitted its listing application to the main board of the Hong Kong Stock Exchange, with CITIC Securities as its sole sponsor.
According to the Hong Kong Stock Exchange disclosure on July 9th, Jiangsu Zhiyuan Pharmaceutical Co., Ltd. (referred to as Zhiyuan Pharmaceutical) has submitted its listing application to the Hong Kong Stock Exchange main board, with CITIC SEC as its sole sponsor. According to the prospectus, the company is a Chinese pharmaceutical company focusing on the field of dermatology, with leading products in multiple treatment areas, providing a comprehensive solution covering skin medications and medical-grade skincare products from head to toe.
Related Articles
DALIPAL HLDG(01921) spent HK$926,500 on July 9 to buy back 304,000 shares.
Nexchip Semiconductor Corporation (02249): Hong Kong Public Offering Receives 344.26 Times Oversubscription
US Stock Market Move | Shares of concept stock in optical communications rose across the board, with Lumentum (LITE.US) up over 12%.
DALIPAL HLDG(01921) spent HK$926,500 on July 9 to buy back 304,000 shares.
Nexchip Semiconductor Corporation (02249): Hong Kong Public Offering Receives 344.26 Times Oversubscription
US Stock Market Move | Shares of concept stock in optical communications rose across the board, with Lumentum (LITE.US) up over 12%.
RECOMMEND
